Latest News by Industry
SAN DIEGO (AP) — SAN DIEGO (AP) — Capricor Therapeutics Inc. (CAPR) on Wednesday reported a loss of $7.7 million in its fourth quarter.
The San Diego-based company said it had a loss of 31 cents per share.
The biotechnology company posted revenue of $959,900 in the period. Its adjusted revenue was $960,000.
For the year, the company reported that its loss widened to $29 million, or $1.18 per share. Revenue was reported as $2.6 million.
In the final minutes of trading on Wednesday, the company's shares hit $4.47. A year ago, they were trading at $4.14.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a CAPR">Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR